home / stock / bpts / bpts news

BPTS News and Press, Biophytis SA From 02/03/22

Stock Information
Company Name: Biophytis SA
Stock Symbol: BPTS
Market: NASDAQ
Menu
BPTS BPTS Quote BPTS Short BPTS News BPTS Articles BPTS Message Board
Get BPTS Alerts

News, Short Squeeze, Breakout and More Instantly...
BPTS - Biophytis Received Approval from ANVISA (Brazil) to Give Access to Sarconeos (BIO101) to Hospitalized COVID-19 Patients through an Expanded Access Program

ANVISA (Brazilian Health Authority) approved Biophytis' Expanded Access Program (EAP) for hospitalized patients with severe COVID-19 and mechanically ventilated in Intensive Care Unit Sarconeos (BIO101) treatment will be given to a maximum of 80 patients mechanically ventilated in Inte...
BPTS - Biophytis Announces the Drawing of the Last Tranche of ORNANE Under the 2020 Atlas Contract for Euro3 Million

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / December 22, 2021 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, including severe respirato...

BPTS - Biophytis to Meet with FDA to Advance Sarconeos (BIO101) Development in Sarcopenia from Phase 2 to Phase 3

Following Phase2b/SARA-INT clinically meaningful results, Biophytis is starting first regulatory activities to advance from Phase 2 to Phase 3 development A Type B/End-of-Phase 2 meeting is planned with FDA (Food and Drug Administration) on January 24th, 2022, to discuss these results ...

BPTS - MTTR, TDG and HXL among mid-day movers

Gainers: Krystal (NASDAQ:KRYS) +116%. Petros Pharmaceuticals (NASDAQ:PTPI) +106%. Adagio (NASDAQ:ADGI) +72%. iSpecimen (NASDAQ:ISPC) +38%. Avenue (NASDAQ:ATXI) +27%. Biophytis (NASDAQ:BPTS) +19%. NRx Pharmaceuticals (NASDAQ:NRXP) +19%. Matterport (NASDAQ:MTTR) +18%. Stran & Company (NASDA...
BPTS - Biophytis Obtains a New 10MEuro Loan Structure With Kreos Capital

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 22, 2021 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris: ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with a...

BPTS - Biophytis to restart U.S. recruitment for COVA Phase 2-3 study with Sarconeos in COVID-19

Biophytis (NASDAQ:BPTS) announces that patient recruitment in the U.S., paused in May while waiting for results of the Interim Analysis 2, has restarted. The Data Monitoring Committee (DMC) had recommended in September the continuation of the COVA study unmodified based on results showing the...

BPTS - Biophytis Announces US Centers to Restart Recruitment for the COVA Phase 2-3 Study with Sarconeos (BIO101) in COVID-19

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 15, 2021 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris: ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with...
BPTS - Biophytis to Report Restated Financial Statements for Previous Periods and as of June 30, 2021

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 29, 2021 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with agi...

BPTS - Biophytis to Restate Previously Issued Financial Statements

PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS) (the “Company” or “Biophytis”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative ...

BPTS - Biophytis to Host Virtual KOL Event on Sarconeos (BIO101) on its Lead Projects in COVID-19 and Sarcopenia

PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outc...
Previous 10 Next 10